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Background: Circadian rhythms are characterized by approximate 24-hour oscillations in physio-
logical and behavioral processes. Disruptions in these endogenous rhythms, most commonly associated
with shift work and/or lifestyle, are recognized to be detrimental to health. Several studies have
demonstrated a high correlation between disrupted circadian rhythms andmetabolic disease. The aimof
this study was to determine which metabolic parameters correlate with physiological measures of
circadian temperature amplitude (TempAmp) and stability (TempStab).
Methods:Wrist skin temperaturewasmeasured in 34 subjects (ages 50 to 70, including lean, obese, and
diabetic subjects) every 10 minutes for 7 consecutive days. Anthropometric measures and fasting blood
draws were conducted to obtain data on metabolic parameters: body mass index, hemoglobin A1C,
triglycerides, cholesterol, high-density lipoprotein, and low-density lipoprotein. A history of hyper-
tension and current blood pressure was noted.
Results: Analysis of the data indicated a substantial reduction in TempAmp and TempStab in subjects
with metabolic syndrome (three or more risk factors). To determine the impact of individual in-
terdependent metabolic factors on temperature rhythms, stepwise multilinear regression analysis was
conducted using metabolic syndrome measurements. Interestingly, only triglyceride level was con-
sistently correlated by the analysis. Triglyceride level was shown to contribute to 33% of the variability
in TempAmp and 23% of the variability in TempStab.
Conclusion: Our results demonstrate that elevated triglycerides are associated with diminished
TempAmp and TempStab in human subjects, and triglycerides may serve as a primary metabolic
predictor of circadian parameters.
Copyright © 2017 Endocrine Society
This article has been published under the terms of the Creative Commons Attribution Non-
Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-
nd/4.0/).
Freeform/Key Words: triglycerides, obesity, metabolic syndrome, circadian rhythm
Circadian rhythms, or the 24-hour oscillations in physiological and behavioral processes, are
essential to health [1, 2]. These rhythms are generated by a molecular clock present in every
cell of an organism and entrained to environmental cues [3–5]. In mammals, themaster clock
is located in the suprachiasmatic nucleus of the hypothalamus and serves to orchestrate
synchronization among all other clocks in the body, referred to as peripheral clocks [6, 7].
Impaired or desynchronized rhythms among tissues have been shown to be connected to a
Abbreviations: BMI, bodymass index; BP, blood pressure; HbA1C, hemoglobin A1C;HDL, high-density lipoprotein; LDL, low-density
lipoprotein; MetS, metabolic syndrome; TempAmp, temperature amplitude; TempStab, temperature stability; TG, triglycerides.
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multitude of the diseases that plague us today, including cardiovascular disease, metabolic
disease, cancer, and stroke [1, 8, 9]. Many studies have demonstrated a link between met-
abolic disease and circadian rhythms. Night shift workers have been shown to have increased
risk of diabetes [10]. Misalignment of feeding and light cycles causes desynchronization of
clocks and development of metabolic syndrome (MetS) in mice [11]. In addition, irregular
activity rhythms, independent of total activity, are linked to elevated risk of dyslipidemia,
hypertension, obesity, diabetes, and MetS in adults [12].
In a previous study, we demonstrated a substantial decrease in circadian amplitude and
stability of temperature rhythms in youngmenwith higher body fat or the presence of at least
one factor of MetS [13]; however, body fat is only one of a variety metabolic characteristics.
Although it is well established that metabolism and circadian rhythms are interdependent, it
is still unclear whether certain metabolic aspects are more strongly associated with circadian
rhythms [3, 14, 15]. To investigate this, we collected fasting laboratory values and anthro-
pometric measurements and evaluated circadian rhythms by measuring wrist skin tem-
perature, which has been validated as a good circadian assessment [16–19]. Because MetS
becomes muchmore prevalent with age, we recruited participants between the ages of 50 and
70 years with a body mass index (BMI) of 27 to 40 kg/m2. Using wrist skin temperature data
from these individuals, we were able to compare circadian temperature amplitude (Tem-
pAmp) and stability (TempStab) toMetS associated factors such as BMI, blood pressure (BP),
hemoglobin A1C (HbA1C), cholesterol, high-density lipoprotein (HDL), low-density lipo-
protein (LDL), and triglycerides (TG). Our findings demonstrate that TG is the most sub-
stantial factor associated with both TempAmp and TempStab and that as TG levels
increase, a reduction in TempAmp and TempStab is observed.
1. Methods
A. Subjects
Participants were recruited on a volunteer basis through institutional review board–
approved advertisements such as flyers, Web postings (University of Kentucky Clinical
Research), and ResearchMatch. Thirty-four subjects of both sexes between the ages of 50 and
70 years and a BMI of 27 to 40 kg/m2 were included in this study. Individuals with limited
mobility, renal disease, severe heart failure, shift work, unpredictable social situations,
obstructive sleep apnea, and uncontrolledmental health disorders were excluded. Thewomen
included in the study were postmenopausal or had previously undergone a hysterectomy. All
subjects were euthyroid with a normal thyrotropin. Among the 34 subjects, 10 had diagnosed
type 2 diabetes, of which five were being treated with insulin. MetS was defined as the
presence of at least three metabolic risk factors [20]. These risk factors include TG$150 mg/dL,
fasting blood glucose $100 mg/dL, BP $130/85 mm Hg (elevated systolic or diastolic), or a
history of hypertension and on treatment, HDL ,40 in men or ,50 in women, and waist
circumference $35 or 40 inches in women or men, respectively. Of the 34 subjects, 18
had a history of hypertension and were on medications; of the other 16 subjects without a
history of hypertension, only two exhibited hypertension (systolic BP. 140 mmHg, diastolic
BP . 90 mm Hg) at the screening visit.
Preceding the initiation of the study, each individual signed an informed consent as ap-
proved by the University of Kentucky institutional review board.
B. Vital Signs and Blood Sampling
Participants were weighed using a calibrated scale, and standing height was determined by
measurement with a wall-fixed stadiometer for calculation of BMI. Heart rate and BP were
measured after participants had been seated a minimum of 5 minutes. Blood laboratory
values were drawn after an overnight (.8 hours) fast, and samples were sent to Quest Di-
agnostics (Madison, NJ) for analysis of lipids, thyrotropin, and HbA1C.
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C. Circadian Rhythm Assessment
Circadian analysis was done using noninvasive wrist skin temperature measurements as
described by us previously [13]. Wrist skin temperature was monitored and recorded every
10 minutes with a sensitivity of 0.0625°C using the iButton device (Thermochron iButton; Em-
bedded Data Systems, Lawrenceburg, KY). Participants were instructed to wear the iButton on
the inside nondominant-hand wrist for 7 consecutive days. The iButton was secured to the wrist
with strips of latex-free dressing tape (Hypafix; Smith & Nephew Inc, Memphis, TN) and a
cotton sports wrist band provided to the participants. Subjects were instructed to limit the
removal of the iButton (i.e., bathing) to limit disruptions in recordings. Data were transferred
from the iButton through an adapter (SK-IB-R-iButton Connectivity Kit; Embedded Data
Systems). Recorded data from 7 days wearing the iButton were used to determine the circadian
amplitude and stability using the software program JTK-Cycle [13, 21]. Amplitude is defined by
the peak and midline values. Stability was defined as the variation in the oscillatory pattern of
the individual’s circadian data over the days of data collection.
D. Statistical Analysis
Subjects were categorized as either having MetS or no MetS; corresponding descriptive data
are shown as mean 6 standard deviation for continuous variables and count (%) for cate-
gorical variables. Comparisons were made via the use of two-sample t tests and Fisher exact
tests. Pearson correlations were used to quantify associations between continuous variables
in bivariate analyses, whereas multiple linear regression was used when numerous variables
were used as predictors of TempAmp and TempStab. For estimates from the regression
models to correspond to adjusted Pearson correlations, variables were centered and stan-
dardized. All tests were two-sided, and statistical significance for all tests was set at P# 0.05.
Analyses were conducted inGraphPad Prism (version 5, GraphPad Software, SanDiego, CA),
Statistical Package for Social Sciences (version 23, Armonk, NY), and SAS version 9.4 (SAS
Institute, Cary, NC).
2. Results
Previous research has demonstrated diminished temperature rhythms in individuals with
MetS [12, 13, 16, 22, 23]. We verified this relationship in our own study population by
comparing TempAmp and TempStab between subjects with MetS (3+ risk factors) and those
without MetS (0 to 2 risk factors). Individuals with MetS displayed a significantly lower
TempAmp (MetS: 0.656 0.12 vs noMetS: 0.986 0.08,P = 0.03) and TempStab (MetS: 79.966
16.87 vs no MetS: 131.50 6 13.23, P = 0.04) (Fig. 1).
MetS involves a number of clinical features, some ofwhichmay have stronger relationships
with circadian rhythms than others. We were interested in determining how specific met-
abolic factors tracked with TempAmp and TempStab (Table 1). Using data on BMI, age, sex,
HbA1C, cholesterol, HDL, TG, LDL, and BP, we determined the correlation between each
parameter and TempAmp or TempStab (Table 2). As seen in Fig. 2, univariate regression
exhibited significant correlations for TGwith TempAmp (r =20.58,P, 0.001) and TempStab
(r = 20.48, P , 0.001). Although TG, HbA1C, and HDL all showed univariate correlations
with TempAmp and TempStab (Table 2), these metabolic factors, and others we examined,
are not independent of each other. Therefore, to evaluate the adjusted associations between
each metabolic variable and TempAmp and TempStab, we used multiple linear regression
analyses (Table 2). Multivariate analysis revealed TG (TempAmp: r = 20.58, P , 0.001;
TempStab: r =20.48,P, 0.001) as the sole factor significantly correlatedwith TempAmpand
TempStab. The relationship between TG and TempAmp can be seen in the representative
temperature traces from two subjects in Fig. 3.
These data included all 34 subjects, but we also examined the relationship between TG and
TempAmp and TempStab in the diabetic subjects alone (Table 3). Stepwise multilinear
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regression analysis created two models for TempAmp, both of which include TG. The first
model identifies TG as the only explanatory variable, contributing 68% to the variability of
TempAmp (r =20.82, P = 0.001). The secondmodel uses both age (r = 0.413, P, 0.05) and TG
(r = 20.765, P , 0.01) to explain the variability of TempAmp. The model for TempStab,
however, includes TG only (r =20.75, P, 0.05), with TG explaining 56% of the variability of
TempStab. Therefore, even in the smaller subset of diabetic participants, TG is the most
prominent factor affecting TempAmp and TempStab. Overall, these data suggest that TG has
the greatest impact on circadian temperature rhythms and is the predominant MetS marker
for disrupted circadian rhythms.
3. Discussion
A number of physiological processes in the human body oscillate over the course of a 24-hour
day. One such process that is highly linked at both the cellular and systems level to circadian
rhythms is metabolism [2, 3, 24, 25]. As previously mentioned, circadian rhythm disrup-
tion and MetS are highly associated [22, 23, 26], but MetS encompasses a variety of
Table 1. Baseline Features of Participants With and Without MetS
No MetS (<3 Risk Factors) MetS (3+ Risk Factors) P Value
BMI 28.9 6 4.3 34.2 6 5.3 0.01
Systolic BP (mm Hg) 115.5 6 12.2 128.6 6 9.9 0.01
Diastolic BP (mm Hg) 68.7 6 10.0 76.9 6 6.6 0.03
Waist (inches) 38.8 6 6.7 44.9 6 5.5 0.02
HDL 69.4 6 17.8 44.4 6 16.6 ,0.001
Triglycerides (mg/dL) 89.9 6 12.8 179.4 6 50.3 ,0.001
Glucose (mg/dL) 90.3 6 12.8 117.7 6 32.9 ,0.001
HbA1C 5.6 6 0.4 6.5 6 1.2 ,0.001
Diagnosed hypertension (%) 0.01
Yes 9 (37.5) 9 (90)
No 15 (62.5) 1 (10)
Patients with diabetes (%) 0.16
Yes 3 (12.5) 4 (40.0)
No 21 (87.5) 6 (60.0)
Sex (%) 0.40
Male 5 (20.8) 4 (40.0)
Female 19 (79.2) 6 (60.0)
Data shown as mean 6 standard deviation. P values of ,0.05 are shown in italics.
Figure 1. Temperature amplitude and stability data for MetS groups. (a) Circadian
amplitude for individuals with MetS (more than three risk factors) (n = 10) or without MetS
(n = 24) (P = 0.023). (b) Circadian stability for individuals with MetS (n = 10) or without
MetS (n = 24) (P = 0.049).
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measurements; it is still unclear how strongly each factor relates to temperature rhythms.
Therefore, the goal of this studywas to begin to identify which variables serve as the strongest
predictors of two parameters of circadian rhythms: TempAmp or TempStab.
Based on a previous publication in which fat mass was exposed as an explanatory variable
for temperature stability in youngmen [18], we expectedBMI to be included in themultilinear
regression models for TempAmp and TempStab. Interestingly, BMI was not correlated in
either model and rather TG was the primary predictor of TempAmp and TempStab. In fact,
Table 2. Correlation Coefficients Between Demographic and Clinical Features and TempAmp and
TempStab
Amplitude Stability
Variable Pearson r P Value Pearson r P Value
Univariate analysis
BMI 20.217 0.218 20.097 0.583
Sex 0.142 0.424 0.234 0.183
Age 0.105 0.554 0.026 0.882
HbA1C 20.450 0.008 20.400 0.009
Cholesterol 0.126 0.478 0.083 0.642
HDL 0.454 0.008 0.305 0.080
TG 20.577 0.000 20.480 0.004
LDL 0.057 0.748 0.063 0.725
Systolic BP 0.100 0.574 20.047 0.791
Diastolic BP 20.163 0.356 20.208 0.239
Diagnosed hypertension 0.223 0.206 0.221 0.209
Multivariate analysis
BMI 0.071 0.672 0.166 0.353
Sex 20.017 0.914 0.112 0.498
Age 0.220 0.136 0.120 0.456
HbA1C 20.132 0.494 20.155 0.455
Cholesterol 0.013 0.931 20.012 0.939
HDL 0.147 0.441 0.000 0.999
TG 20.577 0.000 20.480 0.004
LDL 20.036 0.809 20.014 0.928
Systolic BP 0.285 0.057 0.095 0.563
Diastolic BP 0.017 0.914 20.065 0.695
Diagnosed hypertension 20.030 0.853 0.019 0.916
P values of ,0.05 are shown in italics.
Figure 2. Correlation data. (a) Linear regression for triglycerides (mg/dL) and temperature
amplitude (r = 20.58, P , 0.001). (b) Linear regression for triglycerides (mg/dL) and
temperature stability (r = 20.48, P , 0.01). N = 34.
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TGwas the only explanatory factor and accounted for 33% of the variability in TempAmp and
23% of the variability in TempStab. The predicting power of TG was further supported by our
analysis of the patientswith diabetes alone. TGwas included in themodels for bothTempAmp
and TempStab for patients with diabetes, and accounted for an even greater proportion of
the TempAmp (68%) and TempStab (56%). The greater impact of TG as an explanatory
variable in patients with diabetes could be due to the smaller group size (n = 10), but it is still
compelling evidence for TG as the main metabolic component related to temperature
rhythms.
Although regression analyses provide information on the variables’ contribution to vari-
ance, they do not specify cause and effect. The data do not indicate why TG is correlated with
temperature rhythms and or why it is themost important predicting factor. We know that TG
levels are regulated in part by circadian rhythms [27–32]. As such, it could be that diminished
circadian amplitude and stability in our participants led to high TG levels. This is feasible
considering previous publications regarding animals and humans demonstrating the de-
velopment of MetS following circadian clock disruption [2, 24, 33]. In contrast, it could be that
abnormal metabolic parameters led to diminished circadian rhythms. Elevated TG may
indicate increased insulin secretion [34–36]. A number of studies have demonstrated that
hypertriglyceridemia is a consequence of increased hepatic triglyceride production in
Figure 3. Representative 7-day traces for temperature amplitude in an individual with (a)
low triglycerides and (b) high triglycerides. Shaded regions indicate typical dark hours,
whereas nonshaded regions represent typical light hours. As seen by the traces, the
amplitude of temperature oscillation over time of day is diminished with high levels of
triglycerides.
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response to inflated postprandial insulin secretion [37, 38]. The liver is central to the reg-
ulation of lipid metabolism, and prior research has shown insulin can phase shift the ex-
pression of core clock gene Per2 in the liver, which ultimately shifts the hepatic clock [39]. A
phase shift of the hepatic clock could result in dyssynchrony between the master (supra-
chiasmatic nucleus) clock and peripheral tissues. Phase shifting or dyssynchrony may con-
tribute to diminished circadian rhythm parameters [39]. Further research is needed to define
the relationship between TG and circadian parameters.
Another surprising finding of this study was that TG had a greater association with
temperature rhythms than did hypertension or BP. As seen in Fig. 2, systolic BP, diastolic
BP, and diagnosed hypertension were all included in the multivariate regression
analysis. None of these parameters was correlated in the model. Most of the subjects in
this study were being treated for hypertension; hence, this study cannot precisely report
the relationship between temperature rhythms and BP. In summary, our data show a
substantial relationship between circadian rhythms and circulating TG levels in adults.
Our analyses demonstrate TG as the most prevalent predictor of TempAmp and
TempStab, which has not previously been shown. Disrupted circadian rhythms are re-
lated to a variety of diseases, including cardiovascular disease, obesity, strokes, and
cancer [1, 8, 9]. Because of the relationship between TG and circadian parameters, this
metabolic parameter may possibly be used to assess risk of circadian-related diseases. If
TG levels not only predict circadian parameters, but affect them as well, TG may serve
as a target to improve circadian rhythmicity. However, further investigation is required
to both establish the causality between the investigated metabolic factors and circadian
rhythms.
Table 3. Correlations With TempAmp and TempStab in Patients With Diabetes
Diabetic
Amplitude Stability
Variable Pearson r P Value Pearson r P Value
Univariate analysis
BMI 20.607 0.062 20.424 0.222
Sex 0.165 0.648 0.274 0.443
Age 0.521 0.122 0.503 0.138
HbA1C 20.630 0.051 20.628 0.052
Cholesterol 20.038 0.918 20.003 0.993
HDL 0.563 0.090 0.510 0.132
TG 20.823 0.003 20.750 0.012
LDL 0.033 0.927 0.068 0.852
Systolic BP 20.311 0.381 20.322 0.364
Diastolic BP 20.432 0.212 20.349 0.322
Diagnosed hypertension 0.623 0.054 0.416 0.232
Multivariate analysis Model 1 Model 2
BMI 20.286 0.230 20.162 0.400 20.096 0.743
Sex 20.101 0.664 20.056 0.751 0.045 0.868
Age 0.413 0.029 0.430 0.029 0.406 0.083
HbA1C 20.168 0.559 20.151 0.485 20.245 0.461
Cholesterol 20.287 0.185 20.171 0.332 20.228 0.383
HDL 20.524 0.194 20.152 0.688 20.488 0.310
TG 20.823 0.003 20.765 0.001 20.750 0.012
LDL 20.270 0.227 20.178 0.308 20.204 0.448
Systolic BP 20.013 0.958 0.089 0.626 20.055 0.842
Diastolic BP 20.215 0.337 20.039 0.841 20.148 0.580
Diagnosed hypertension 0.347 0.118 0.082 0.740 0.134 0.633
P values of ,0.05 are shown in italics.
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